TCM
ENZN

Tradewinds Capital Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Tradewinds Capital Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-200
Closed – – 726
2016
Q2 		$0 Buy
+200
New +$99 ﹤0.01% 703
2016
Q1 		– Sell
-200
Closed – – 723
2015
Q4 		$0 Hold
200
– – ﹤0.01% 712
2015
Q3 		$0 Hold
200
– – ﹤0.01% 750
2015
Q2 		$0 Hold
200
– – ﹤0.01% 712
2015
Q1 		$0 Hold
200
– – ﹤0.01% 671
2014
Q4 		$0 Hold
200
– – ﹤0.01% 674
2014
Q3 		$0 Hold
200
– – ﹤0.01% 659
2014
Q2 		$0 Hold
200
– – ﹤0.01% 668
2014
Q1 		$0 Hold
200
– – ﹤0.01% 668
2013
Q4 		$0 Buy
+200
New +$308 ﹤0.01% 608

Other funds holding ENZN

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Tradewinds Capital Management's ENZN Position: Q3 2016 in Review

Tradewinds Capital Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2016, closing a stake of 200 shares.

Tradewinds Capital Management first reported a position in ENZN in Q4 2013 and held it in 10 quarters. The position peaked at $0 in Q2 2016. 4 funds tracked by Wall St. Rank hold ENZN as of Q3 2016.

  • Tradewinds Capital Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2016 after selling out during the quarter.
  • Tradewinds Capital Management sold 200 ENZON PHARMACEUTICALS INC shares in Q3 2016.
  • Tradewinds Capital Management first reported a position in ENZON PHARMACEUTICALS INC in Q4 2013 and held it in 10 quarters.
  • Tradewinds Capital Management's ENZON PHARMACEUTICALS INC position peaked at $0 in Q2 2016.
  • 4 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2016.

Based on Tradewinds Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.